Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid crisis in the US for up to $4.25 billion, including already ...

EU fines Teva €462.5m for artificially extending the patent protection for former multiple sclerosis blockbuster Copaxone.